Wang, X., hui, yang, Wang, S., Hu, X., Yu, X., Wang, W., … Liu, L. (2020). Comparison of effectiveness and safety outcomes of abiraterone versus enzalutamide in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis: Abiraterone versus enzalutamide in mCRPC. Journal of Pharmacy & Pharmaceutical Sciences, 23, 451–461. https://doi.org/10.18433/jpps31003